{"id":4297,"date":"2026-04-09T11:41:00","date_gmt":"2026-04-09T11:41:00","guid":{"rendered":"https:\/\/avelife.pro\/superbug-resistance-and-synthesis-of-new-pharmaceutical-reagents\/"},"modified":"2026-04-14T14:47:50","modified_gmt":"2026-04-14T14:47:50","slug":"superbug-resistance-and-synthesis-of-new-pharmaceutical-reagents","status":"publish","type":"post","link":"https:\/\/avelife.pro\/en\/superbug-resistance-and-synthesis-of-new-pharmaceutical-reagents\/","title":{"rendered":"Superbug resistance and synthesis of new pharmaceutical reagents"},"content":{"rendered":"\n<h1 class=\"wp-block-heading\">ESKAPE pathogen resistance: Technological standards for the synthesis of reagents for new APIs<\/h1>\n\n<p>The increasing resistance of ESKAPE pathogens (<em>Enterococcus faecium, Staphylococcus aureus, Klebsiella pneumoniae, Acinetobacter baumannii, Pseudomonas aeruginosa, Enterobacter spp.<\/em>) to carbapenems and colistin requires a review of antimicrobial drug development strategies.<\/p>\n\n<p>PubMed data indicate a critical decline in the therapeutic feasibility of modifying existing classes of antibiotics. The priority vector for the pharmaceutical sector is the synthesis of cyclic lipopeptides and efflux pump inhibitors.<\/p>\n\n<figure class=\"wp-block-image size-large\"><img data-recalc-dims=\"1\" fetchpriority=\"high\" decoding=\"async\" width=\"896\" height=\"397\" src=\"https:\/\/i0.wp.com\/avelife.pro\/wp-content\/uploads\/2026\/04\/img_7433.jpg?resize=896%2C397&#038;ssl=1\" alt=\"Resistance analysis of ESKAPE strains.\" class=\"wp-image-4261\" srcset=\"https:\/\/i0.wp.com\/avelife.pro\/wp-content\/uploads\/2026\/04\/img_7433.jpg?w=896&amp;ssl=1 896w, https:\/\/i0.wp.com\/avelife.pro\/wp-content\/uploads\/2026\/04\/img_7433.jpg?resize=300%2C133&amp;ssl=1 300w, https:\/\/i0.wp.com\/avelife.pro\/wp-content\/uploads\/2026\/04\/img_7433.jpg?resize=768%2C340&amp;ssl=1 768w, https:\/\/i0.wp.com\/avelife.pro\/wp-content\/uploads\/2026\/04\/img_7433.jpg?resize=600%2C266&amp;ssl=1 600w, https:\/\/i0.wp.com\/avelife.pro\/wp-content\/uploads\/2026\/04\/img_7433.jpg?resize=3%2C1&amp;ssl=1 3w, https:\/\/i0.wp.com\/avelife.pro\/wp-content\/uploads\/2026\/04\/img_7433.jpg?resize=10%2C4&amp;ssl=1 10w\" sizes=\"(max-width: 896px) 100vw, 896px\" \/><\/figure>\n\n<div style=\"height:20px\" aria-hidden=\"true\" class=\"wp-block-spacer\"><\/div>\n\n<h2 class=\"wp-block-heading\">Resistance mechanisms and chemical response<\/h2>\n\n<p>The main barriers to API efficacy are enzymatic inactivation (beta-lactamases) and modification of binding targets. To overcome these mechanisms, molecules with complex spatial configurations are required. The production of such compounds directly depends on the quality of the pharma intermediates.<\/p>\n\n<p>AVELife specializes in the development of building blocks with fixed stereochemistry, allowing the creation of APIs capable of inhibiting penicillin-binding proteins even in strains with high levels of mutations.<\/p>\n\n<figure class=\"wp-block-video\"><video height=\"720\" style=\"aspect-ratio: 1280 \/ 720;\" width=\"1280\" controls=\"\" loop=\"\" muted=\"\" preload=\"auto\" src=\"https:\/\/avelife.pro\/wp-content\/uploads\/2026\/04\/higgsfield-9ada6809-3005-4264-92d4-a64313717faa.mp4\"><\/video><figcaption class=\"wp-element-caption\">Superbug resistance and synthesis of new pharmaceutical reagents<\/figcaption><\/figure>\n\n<div style=\"height:20px\" aria-hidden=\"true\" class=\"wp-block-spacer\"><\/div>\n\n<h3 class=\"wp-block-heading\">Technological regulations according to the Avelife methodology<\/h3>\n\n<p>Market entry of new antibacterial agents is limited by the toxicity of microimpurities that arise at the synthesis stage. Anatoly Demchenko&#8217;s methodology is based on the use of pre-activated reagents, which radically changes the economics of the process:<\/p>\n\n<ul class=\"wp-block-list\">\n<li><strong>Purify intermediates:<\/strong> Using AVELife catalysts ensures optical purity of reagents &gt;99.5%.<\/li>\n\n\n\n<li><strong>Synthetic yield:<\/strong> Stabilization of intermediate stages allows achieving a yield of the target API of 98%.<\/li>\n\n\n\n<li><strong>Waste minimization:<\/strong> Switching to chlorine-free solvents and low-temperature synthesis modes reduces operational disposal costs.<\/li>\n<\/ul>\n\n<h3 class=\"wp-block-heading\">Operational Benefits for C-level Pharma<\/h3>\n\n<figure class=\"wp-block-video\"><video height=\"768\" style=\"aspect-ratio: 1376 \/ 768;\" width=\"1376\" controls=\"\" loop=\"\" muted=\"\" src=\"https:\/\/avelife.pro\/wp-content\/uploads\/2026\/04\/higgsfield-071283b0-01d2-4b5e-ba11-896f1c7f3498.mp4\"><\/video><\/figure>\n\n<div style=\"height:20px\" aria-hidden=\"true\" class=\"wp-block-spacer\"><\/div>\n\n<p>The introduction of new generation reagents into the API production chain provides strategic advantages:<\/p>\n\n<ol class=\"wp-block-list\">\n<li><strong>Reduction of R&amp;D cycle:<\/strong> Ready-made blocks for the synthesis of complex heterocycles reduce the number of development stages by 25-30%.<\/li>\n\n\n\n<li><strong>Quality Control:<\/strong> Minimizing reaction byproducts makes it easier to pass GMP and FDA certification.<\/li>\n\n\n\n<li><strong>Localization and safety:<\/strong> The use of reagents developed by the institute reduces dependence on volatile external raw material markets.<\/li>\n<\/ol>\n\n<p>Overcoming the superbug resistance crisis is a matter of technological superiority in the purity of synthesis.<\/p>\n\n<blockquote class=\"wp-block-quote is-layout-flow wp-block-quote-is-layout-flow\">\n<p>AVELife&#8217;s highly selective reagents are the foundation for creating the next generation of antibacterial therapy.<\/p>\n<\/blockquote>\n\n<h3 class=\"wp-block-heading\">Scientific verification:<\/h3>\n\n<ul class=\"wp-block-list\">\n<li>PubMed: <a href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/30614325\/\">Antimicrobial resistance in ESKAPE pathogens<\/a><\/li>\n\n\n\n<li>Google Patents: <a href=\"https:\/\/www.google.com\/search?q=https:\/\/patents.google.com\/?q%3Dapi%2Bsynthesis%2Bhigh%2Bpurity%2Breagents\">High-purity reagents for peptide and API synthesis<\/a><\/li>\n\n\n\n<li>AVELife: <a href=\"https:\/\/www.google.com\/search?q=https:\/\/avelife.pro\/reagents\/api-synth\">\u0422\u0435\u0445\u043dTechnical data sheets of API-SYNTH series reagents<\/a><\/li>\n<\/ul>\n","protected":false},"excerpt":{"rendered":"<p>Resistance analysis of ESKAPE strains.. Methodology by A. Demchenko for C-level Pharma.<\/p>\n","protected":false},"author":1,"featured_media":4268,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"_jetpack_memberships_contains_paid_content":false,"footnotes":""},"categories":[309,102],"tags":[435,463,328,191,464],"class_list":["post-4297","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-pharmacology","category-publications","tag-api-sourcing-en","tag-eskape-en","tag-pharma","tag-pharmaceutical-technologies","tag-superbug-resistance"],"aioseo_notices":[],"jetpack_featured_media_url":"https:\/\/i0.wp.com\/avelife.pro\/wp-content\/uploads\/2026\/04\/img_7504-scaled.png?fit=1153%2C644&ssl=1","jetpack_sharing_enabled":true,"_links":{"self":[{"href":"https:\/\/avelife.pro\/en\/wp-json\/wp\/v2\/posts\/4297","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/avelife.pro\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/avelife.pro\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/avelife.pro\/en\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/avelife.pro\/en\/wp-json\/wp\/v2\/comments?post=4297"}],"version-history":[{"count":1,"href":"https:\/\/avelife.pro\/en\/wp-json\/wp\/v2\/posts\/4297\/revisions"}],"predecessor-version":[{"id":4298,"href":"https:\/\/avelife.pro\/en\/wp-json\/wp\/v2\/posts\/4297\/revisions\/4298"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/avelife.pro\/en\/wp-json\/wp\/v2\/media\/4268"}],"wp:attachment":[{"href":"https:\/\/avelife.pro\/en\/wp-json\/wp\/v2\/media?parent=4297"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/avelife.pro\/en\/wp-json\/wp\/v2\/categories?post=4297"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/avelife.pro\/en\/wp-json\/wp\/v2\/tags?post=4297"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}